News
NBTX
6.00
+2.74%
0.16
Analysts Offer Insights on Healthcare Companies: Nanobiotix (NBTX), AnaptysBio (ANAB) and PTC Therapeutics (PTCT)
TipRanks · 2d ago
Weekly Report: what happened at NBTX last week (0422-0426)?
Weekly Report · 2d ago
Nanobiotix’s Revenue at Risk: The High Stakes of Sole Dependence on Janssen Partnership
TipRanks · 6d ago
Nanobiotix FY 2023 GAAP EPS $(1.17) Beats $(1.66) Estimate, Sales $39.323M Beat $13.680M Estimate
Nanobiotix reported quarterly losses of $1.17 per share and sales of $39.323 million. The company beat the analyst consensus estimate for quarterly losses by 29.52 percent. Nanobiotx also reported a 681.30 percent increase in sales from the same period last year.
Benzinga · 04/24 21:42
Nanobiotix Sa ADR Reports Promising 2023 Progress
TipRanks · 04/24 21:27
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Conference call and webcast scheduled for April 25, 2024. NANOBIOTIX is a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer. The company reported financial results for the year ended December 31, 2023.
Barchart · 04/24 15:40
Weekly Report: what happened at NBTX last week (0415-0419)?
Weekly Report · 04/22 09:25
Nanobiotix Sa ADR Sets Q4 and Full Year Results Date
TipRanks · 04/17 20:57
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
NANOBIOTIX will report its financial and operational results for the fourth quarter and full year ended December 31, 2023, on April 24, 2024. The company is a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for cancer patients.
Barchart · 04/17 15:15
Weekly Report: what happened at NBTX last week (0408-0412)?
Weekly Report · 04/15 09:23
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Shares of CarMax, Inc. Fell sharply in today’s pre-market trading after the company reported lower-than-expected fourth-quarter earnings. CarMax shares dipped 9.1% to $72.06 in pre- market trading. The Lovesac Company shares fell 13% after reporting worse- than-expected results. The Dow futures fell over 150 points on Thursday.
Benzinga · 04/11 12:03
Nanobiotix Sa ADR Updates Share Capital Info
TipRanks · 04/11 08:40
Voting Rights and Shares Capital of the Company
Barchart · 04/10 15:15
Weekly Report: what happened at NBTX last week (0401-0405)?
Weekly Report · 04/08 09:24
Nanobiotix Advances NBTXR3 for Lung Cancer Treatment
TipRanks · 04/02 20:58
NANOBIOTIX ANNOUNCES COMPLETION OF PHASE 1 DOSE ESCALATION AND NBTXR3 RECOMMENDED PHASE 2 DOSE FOR THE TREATMENT OF INOPERABLE, RECURRENT LUNG CANCER IN PATIENTS AMENABLE TO RE-IRRADIATION
Reuters · 04/02 20:15
Weekly Report: what happened at NBTX last week (0325-0329)?
Weekly Report · 04/01 09:24
Weekly Report: what happened at NBTX last week (0318-0322)?
Weekly Report · 03/25 09:25
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Science Applications International Corporation shares dipped 10.7% to $127.29 on Monday. The company reported financial fourth-quarter EPS below estimates. Canoo Inc. Shares surged 95% after the US Department of Commerce approved its Oklahoma City facility as a Foreign Trade Zone.
Benzinga · 03/18 18:37
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
More
Webull provides a variety of real-time NBTX stock news. You can receive the latest news about Nanobiotix S.A. through multiple platforms. This information may help you make smarter investment decisions.
About NBTX
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.